domingo, 8 de enero de 2012

Health care providers and direct-to-consumer acce... [Genome Med. 2011] - PubMed - NCBI

Genome Med. 2011 Dec 28;3(12):81. [Epub ahead of print]

Health care providers and direct-to-consumer access and advertising of genetic testing in the United States.

Source

Genetic Counseling Graduate Program, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Burnet Avenue, Cincinnati, OH 45229, USA. Melanie.myers@cchmc.org .

Abstract

ABSTRACT: Marketing pressures, regulatory policies, clinical guidelines, and consumer demand all affect health care providers' knowledge and use of health-related genetic tests that are sold and/or advertised to consumers. In addition, clinical guidelines, regulatory policies, and educational efforts are needed to promote the informed use of genetic tests that are sold and advertised to consumers and health care providers. A shift in culture regarding the regulation of genetic tests that are sold directly to consumers is suggested: by recent actions taken by the US Food and Drug Administration (FDA), including letters sent to direct-to-consumer (DTC) genetic testing companies stating that their tests meet the definition of medical devices; by public meetings held by the FDA to discuss laboratory developed tests; and by the convening of the Molecular and Clinical Genetics Panel to gather input on scientific issues concerning DTC genetic tests that make medical claims. This review provides a brief overview of DTC advertising and the regulation of pharmaceuticals and genetic tests in the United States. It highlights recent changes in the regulatory culture regarding genetic tests that are sold to consumers, and discusses the impact on health care providers of selling and advertising genetic tests directly to consumers.

PMID:
22204616
[PubMed - as supplied by publisher]
Health care providers and direct-to-consumer acce... [Genome Med. 2011] - PubMed - NCBI

No hay comentarios:

Publicar un comentario